Hydroxylamine → Ethyl 3-(4-(N-(3-chloro-4-fluorophenyl)-N'-hydroxycarbamimidoyl)-1,2,5-oxadiazol-3-yl)propanoate
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([NH:9][C:10]([C:12]2[C:13]([CH2:17][CH2:18][C:19]([O:21][CH2:22][CH3:23])=[O:20])=[N:14][O:15][N:16]=2)=O)[CH:5]=[CH:6][C:7]=1[F:8].P(Cl)(Cl)(Cl)(Cl)Cl.[NH2:30][OH:31]>C1C=CC=CC=1.CO>[Cl:1][C:2]1[CH:3]=[C:4]([NH:9][C:10]([C:12]2[C:13]([CH2:17][CH2:18][C:19]([O:21][CH2:22][CH3:23])=[O:20])=[N:14][O:15][N:16]=2)=[N:30][OH:31])[CH:5]=[CH:6][C:7]=1[F:8]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
Ethyl 3-(4-[(3-chloro-4-fluorophenyl)amino]carbonyl-1,2,5-oxadiazol-3-yl)propanoate (27 mg, 0.079 mmol) was suspended in benzene (1 mL) under an atmosphere of nitrogen and phosphorus pentachloride (18.0 mg, 0.086 mmol) was added. The solution was heated to reflux for 2.5 h. The solvent was removed in vacuo. The residue was dissolved in EtOH (1.0 mL) and hydroxylamine (100 μL, 2 mmol) (50% solution in water) was added to the reaction. After stirring 1 h, the solution was diluted with MeOH and purified by preparative LCMS to give the desired product (8.5 mg, 30%). 1H NMR (400 MHz, CD3OD): δ 7.03 (t, J=8.9 Hz, 1H), 6.95 (dd, J=6.4, 2.7 Hz, 1H), 6.71 (m, 1H), 4.12 (q, J=7.2 Hz, 2H), 3.11 (t, J=7.2 Hz, 2H), 2.80 (t, J=7.2 Hz, 2H), 1.23 (t, J=7.2 Hz, 3H); LCMS for C14H15ClFN4O4 (M+H)+: m/z=357.1.
Workup
- temperatureThe solution was heated
- temperatureto reflux for 2.5 h
- customThe solvent was removed in vacuo
- dissolutionThe residue was dissolved in EtOH (1.0 mL)
- custompurified by preparative LCMS
Sources & evidence
- ORD record
- ord-8e0eb1447d4647b692bd301e740bae9b
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08450351B2
Reaction notes
Loading…